Ramelteon

This classification denotes a cns stimulant with the molecular formula C16H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 901AS54I69, chemically known as (s)-n-(2-(1,6,7,8-tetrahydro-2h-indeno-(5,4)furan-8-yl)ethyl)propionamide but generally known as ramelteon, which bears US NIH Compound Identifier 208902. European Medicines Agency schedules Ramelteon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21315. The term RAMELTEON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 3, 2004, List 52). World Health Organization schedules ramelteon in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule ramelteon under HS 29329970 and SITC 51569. As of Q4 2014, RAMELTEON remains the US FDA Preferred Term for this commodity. Ramelteon bears US NLM identifiers UMLS ID C1565316 and NCI Concept Code C66504. SMILES: O1C2C(C3C(CCC3CC2)CCNC(=O)CC)CC1.